Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 19th Prioritisation – 2nd quarter 2014. HSO: 19th Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 19th prioritisation (May 2014), 11 were filtered out of 149 identified drugs and were sent to prioritisation. Of these, 6 drugs were ranked as ‘highly relevant’ by the expert panel, 3 as ‘relevant’ and 2 as ‘not relevant’. For ‘highly relevant’ drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
|Series Name:||HSO: 19th Prioritisation|
|Deposited on:||17 Jul 2014 18:53|
|Last Modified:||05 Aug 2016 19:42|
Repository Staff Only: item control page